YTYusuke Tomita

Yusuke Tomita

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yusuke Tomita has a total of 36 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Is annual screening by fecal immunochemical test necessary after a recent colonoscopy?

    by Yutaka Okagawa, Tetsuya Sumiyoshi, Kota Hanada, Sota Hirokawa, Yusuke Tomita, Masahiro Yoshida, Takeyoshi Minagawa, Kohtaro Morita, Kei Yane, Hideyuki Ihara, et al.

    Objective: The population‐based colorectal cancer screening guidelines in Japan recommend an annual fecal immunochemical test (FIT). However, there is no consensus on the need for annual FIT screening for patients who recently performed a total colonoscopy (TCS). Therefore, we evaluated the repeated TCS results for patients with positive FIT after a recent TCS to assess the necessity of an annual FIT.Methods: We reviewed patients with positive FIT in opportunistic screening from April 2017 to March 2022. The patients were divided into two groups: those who had undergone TCS within the previous 5 years (previous TCS group) and those who had not (non‐previous TCS group). We compared the detection rates of advanced neoplasia and colorectal cancer between the two groups.Results: Of 671 patients, 151 had received TCS within 5 years and 520 had not. The detection rates of advanced neoplasia in the previous TCS and non‐previous TCS groups were 4.6% and 12.1%, respectively (p < 0.01), and the colorectal cancer detection rates were 0.7% and 1.5%, respectively (no significant difference). The adenoma detection rates were 33.8% in the previous TCS group and 40.0% in the non‐previous TCS group (no significant difference).Conclusions: Only a few patients were diagnosed with advanced neoplasia among the patients with FIT positive after a recent TCS. For patients with adenomatous lesions on previous TCS, repeated TCS should be performed according to the surveillance program without an annual FIT. The need for an annual FIT for patients without adenomatous lesions on previous TCS should be prospectively assessed in the future.


  • Open Access

    Usefulness of endoscopic ultrasound‐guided transhepatic biliary drainage with a 22‐gauge fine‐needle aspiration needle and 0.018‐inch guidewire in the procedure's induction phase

    by Kei Yane, Masahiro Yoshida, Takayuki Imagawa, Kotaro Morita, Hideyuki Ihara, Kota Hanada, Sota Hirokawa, Yusuke Tomita, Takeyoshi Minagawa, Yutaka Okagawa, et al.

    Endoscopic ultrasound (EUS)‐guided transhepatic biliary drainage is usually performed with a 19‐gauge fine‐needle aspiration (FNA) needle and a 0.025‐inch guidewire. The combination of a 22‐gauge FNA needle and a 0.018‐inch guidewire is reported to be effective as a rescue option when the bile duct diameter is small or technically challenging. Experts in EUS‐guided transhepatic biliary drainage have reported that bile duct puncture with a 19‐gauge FNA needle is possible in most cases, but is not easy to reproduce by endoscopists with less experience in EUS‐guided transhepatic biliary drainage. We investigated the usefulness of EUS‐guided transhepatic biliary drainage using a 22‐gauge FNA needle and a 0.018‐inch guidewire during the procedure's induction phase. Consecutive patients who underwent EUS‐guided transhepatic biliary drainage at our institution from March 2021 to May 2023 were evaluated, and 37 were included. Biliary drainage was performed for malignant bile duct stricture in 36 patients and choledocholithiasis in one patient. The median target bile duct diameter was 4.5 mm (2.5–9.4). Biliary access, fistula dilation, and stent placement were successful in the 37 patients (100%). The median procedure time was 35 min (16–125). Adverse events occurred in four (10.8%) patients. EUS‐guided transhepatic biliary drainage using a 22‐gauge FNA needle and a 0.018‐inch guidewire is a useful and promising option for endoscopists with limited experience in EUS‐guided transhepatic biliary drainage in the procedure's induction phase.


  • Open Access

    A novel technique using a multiloop traction device for colonic diverticular bleeding

    by Yutaka Okagawa, Ryoji Fujii, Tetsuya Sumiyoshi, Mai Fukuda, Yusuke Tomita, Takeyoshi Minagawa, Hitoshi Kondo

    Colorectal endoscopic procedures can be technically difficult in cases of poor endoscopic operability [1] [2]. Recently, the usefulness of traction devices in gastrointestinal endoscopic submucosal dissection has been demonstrated, and there have been several reports on their application in other endoscopic procedures [3] [4]. Herein, we report a case of successful endoscopic hemostasis using a traction device for colonic diverticular bleeding with poor scope operability. A 94-year-old woman was diagnosed with diverticular hemorrhage in the ascending colon, and hemostasis was achieved using endoclips despite poor scope operability ([Fig. 1]). Nonetheless, rebleeding occurred 10 days later. An emergency colonoscopy was performed using a water-jet scope (PCF-H290ZI; Olympus, Tokyo, Japan) with a long distal attachment (MAJ-663; Olympus), which revealed pulsatile bleeding in the same diverticulum where hemostasis had been achieved ([Video 1]). Video 1 Endoscopic hemostasis for diverticular bleeding in the ascending colon was challenging owing to the difficulty of manipulating the scope. The multi-loop traction device improved scope operability and enabled successful hemostasis using endoclips. Owing to the edematous changes associated with the previous hemostatic procedure, the bleeding point was located behind the mucosa ([Fig. 2]). Although endoscopic hemostasis using endoclips was attempted, it was challenging to accurately apply the endoclips to the bleeding point owing to poor scope operability. Although we repositioned the patient to change the scope manipulation, applying an endoclip at the target site was technically impossible. To overcome this challenge, a multi-loop traction device (Boston Scientific Co. Ltd., Tokyo, Japan) was applied to the distal mucosa as close as possible to the diverticulum and anchored to the opposite colonic wall with another endoclip ([Fig. 3]). Fixation of the colonic lumen stabilized the manipulation of the scope. Since the opposite lumen was fixed, the bleeding site did not shift when the endoclip was pressed. Thus, we achieved successful hemostasis without complications ([Fig. 4], [Fig. 5]). In this case, the clips were advantageous for improving scope manipulation, enabling successful hemostasis. Endoscopy_UCTN_Code_TTT_1AQ_2AZ Article published online: 22 September 2022 © 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany


  • Gel immersion endoscopic ultrasonography for the transgastric observation of jejunal tumor

    by Yusuke Tomita, Kei Yane, Tetsuya Sumiyoshi

    Watch a video of this article.


  • Open Access

    Case of needle tract seeding during preoperative neoadjuvant chemotherapy for resectable pancreatic cancer

    by Kei Yane, Mai Aoki, Yusuke Tomita, Masahiro Yoshida, Kotaro Morita, Hideyuki Ihara, Tetsuya Sumiyoshi, Hitoshi Kondo, Yumiko Oyamada

    Reports of needle tract seeding (NTS) as a complication of endoscopic ultrasound‐guided fine‐needle aspiration (EUS‐FNA) have been increasing. To date, most of the reported cases of NTS have been diagnosed during the postoperative follow‐up period. Herein, we report a case of NTS that occurred during preoperative neoadjuvant chemotherapy after EUS‐FNA for resectable pancreatic cancer. The patient underwent transgastric EUS‐FNA for a pancreatic tail tumor. He was diagnosed as having resectable pancreatic cancer and received preoperative neoadjuvant chemotherapy. After completion of the chemotherapy, computed tomography showed a thick‐walled cyst‐like structure appearing between the pancreas and the gastric wall. Combined resection revealed adenocarcinoma invasion into the cyst‐like structure. Based on the clinical course, and surgical and pathological findings, the condition was diagnosed as NTS. It is thus crucial that after EUS‐FNA, a detailed review of the imaging findings be conducted in the preoperative period. If adhesions between the stomach and the pancreas are observed after transgastric EUS‐FNA, combined resection of the gastric wall should be considered.


  • Open Access

    Early gastric mixed neuroendocrine‐non‐neuroendocrine neoplasm with early poor prognosis after endoscopic submucosal dissection: A case report

    by Yusuke Tomita, Hideyuki Seki, Emi Matsuzono, Yoshimitsu Kobayashi, Susumu Sogabe, Nozomu Sugai, Jun Fujita, Akira Suzuki

    Early gastric mixed neuroendocrine‐non‐neuroendocrine neoplasms (MiNENs) are rare diseases, with no data on their incidence and prognosis. We report the case of intramucosal gastric MiNENs for endoscopic submucosal dissection (ESD) treatment. An 80‐year‐old male underwent esophagogastroduodenoscopy for screening and was suspected of early gastric cancer type 0‐IIa+IIc on the lesser curvature of the antrum, for which ESD treatment was performed. Histopathologically, the diagnosis was MiNENs. Synaptophysin‐positive adenoductal structures were observed in the adenocarcinoma component, suggesting that adenocarcinoma had dedifferentiated into neuroendocrine carcinoma. The tumor was located within the mucosal layer, with lympho‐vascular invasion. The patient was kept under observation; however, 6 months after the ESD, computed tomography scan revealed prominent ascites, enlarged lymph nodes, and liver metastases, and MiNENs were suspected to have poor prognosis. If MiNENs diagnosis is made preoperatively or postoperatively, surgical resection may be considered as treatment regardless of the tumor depth or lympho‐vascular invasion.


  • Open Access

    Endocuff-Assisted versus Cap-Assisted Colonoscopy Performed by Trainees: A Retrospective Study

    by Yutaka Okagawa, Tetsuya Sumiyoshi, Yusuke Tomita, Shutaro Oiwa, Fumihiro Ogata, Takashi Jin, Masahiro Yoshida, Ryoji Fujii, Takeyoshi Minagawa, Kohtaro Morita, et al.

    The adenoma detection rate (ADR) of screening colonoscopies performed by trainees is often lower than that of colonoscopies performed by experts. The efficacy of cap-assisted colonoscopy (CAC) in adenoma detection is well documented, especially that of CACs performed by trainees. Endocuff, a new endoscopic cap, is reportedly useful for adenoma detection; however, no trials have compared the efficacy of Endocuff-assisted colonoscopy (EAC) and CAC conducted by trainees. Therefore, the present study retrospectively compared the efficacy between EAC and CAC in trainees. This was a single-center, retrospective study involving 305 patients who underwent either EAC or CAC performed by three trainees between January and December 2018. We evaluated the ADR, mean number of adenomas detected per patient (MAP), cecal intubation rate, cecal intubation time, and occurrence of complications between the EAC and CAC groups. The ADR was significantly higher in the EAC group than in the CAC group (54.3% vs. 37.3%, p=0.019), as was the MAP (1.36 vs. 0.74, p=0.003). No significant differences were found between the groups with respect to the cecal intubation rate or cecal intubation time. No major complications occurred in either group. Our results suggest that EAC exhibits increased ADR and MAP compared to CAC when performed by trainees.